Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Open accessThe DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and is often associated with aspects of metabolic syndrome. Despite its prevalence and the importance of early diagnosis, there is a lack of robustly validated biomarkers for diagnosis, prognosis and monitoring of disease progression in response to a given treatment. In this Review, we provide an overview of the contribution of metabolomics and lipidomics in clinical studies to identify biomarkers associated with NAFLD and nonalcoholic steatohepatitis (NASH). In addition, we highlight the key metabolic pathways in NAFLD and NASH that have been identified by metabolomics and lipidomics approaches and could potentially be used as biomarkers for non-invasive diagnostic tests. Overall, the studies demonstrated alterations in amino acid metabolism and several aspects of lipid metabolism including circulating fatty acids, triglycerides, phospholipids and bile acids. Although we report several studies that identified potential biomarkers, few have been validated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite some limitations regarding sample size, different clinical characteristics of the patients, and the methods of lipidomic profile detection, most of the studies were concordant in showing that individuals with MASLD have higher hepatic accumulation of TAGs, DAGs, ceramides, and dihydroceramides, and in general of lipids rich in SFAs.95”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [95]
In the citing paper
“Individuals with MASH had significantly lower long-chain polyunsaturated fatty acids (PUFAs) and some species of phosphatidylethanolamine (PE), and they had significantly higher lysophosphatidylethanolamine vs. those with isolated steatosis.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [95]
In the citing paper
“In contrast, some lipid species like PCs and LPCs were significantly reduced compared to controls without MASLD.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [95]
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Self-citationEASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
(2012) · Hepatogastroenterology · doi:10.5754/hge12183 · Cited by 1,625
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Shah, A. G., Lydecker, A., Murray, K., Tetri, B. N., Contos, M. J., & Sanyal, A. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.033 · Cited by 1,553
Branched-chain amino acids in metabolic signalling and insulin resistance
Lynch, C. J., & Adams, S. H. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.171 · Cited by 1,461
Lipidomics reveals a remarkable diversity of lipids in human plasma
Quehenberger, O., Armando, A. M., Brown, A. H., Milne, S. B., Myers, D. S., Merrill, A. H., Bandyopadhyay, S., Jones, K. N., Kelly, S., Shaner, R. L., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m009449 · Cited by 1,341
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,063
Chávez-Talavera, O., Tailleux, A., Lefebvre, P., & Staels, B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.055 · Cited by 970
Cajka, T., & Fiehn, O. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04491 · Cited by 830
Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota
Magnúsdóttir, S., Heinken, A., Kutt, L., Ravcheev, D. A., Bauer, E., Noronha, A., Greenhalgh, K., Jäger, C., Baginska, J., Wilmes, P., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3703 · Cited by 798
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134165 · Cited by 771
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
Self-citationIntestinal microbiota in patients with nonalcoholic fatty liver disease
Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749
Jiao, N., Baker, S. S., Chapa-Rodriguez, A., Liu, W., Nugent, C. A., Tsompana, M., Mastrandrea, L., Buck, M. J., Baker, R. D., Genco, R. J., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314307 · Cited by 737
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Hoyles, L., Fernández-Real, J.-M., Federici, M., Serino, M., Abbott, J., Charpentier, J., Heymes, C., Luque, J. L., Anthony, E., Barton, R. H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0061-3 · Cited by 720
Krishnan, S., Ding, Y., Saedi, N., Choi, M., Sridharan, G. V., Sherr, D. H., Yarmush, M. L., Alaniz, R. C., Jayaraman, A., & Lee, K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.109 · Cited by 679
Mancina, R. M., Dongiovanni, P., Petta, S., Pingitore, P., Meroni, M., Rametta, R., Borén, J., Montalcini, T., Pujia, A., Wiklund, O., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.032 · Cited by 676
Haus, J. M., Kashyap, S. R., Kasumov, T., Zhang, R., Kelly, K. R., DeFronzo, R. A., & Kirwan, J. P. (2009) · Diabetes · doi:10.2337/db08-1228 · Cited by 663
The plasma lipidomic signature of nonalcoholic steatohepatitis
Puri, P., Wiest, M. M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H., Contos, M. J., Sterling, R. K., Fuchs, M., Zhou, H., et al. (2009) · Hepatology · doi:10.1002/hep.23229 · Cited by 655
Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Hu, Y., Li, J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep08096 · Cited by 649
Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44442 · Cited by 647
Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.038 · Cited by 631
Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R., Buzzigoli, E., Sironi, A. M., Cersosimo, E., Ferrannini, E., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.068 · Cited by 629
Self-citationThe effect of normalization of plasma amino acids on hepatic encephalopathy in man.
Fischer, J. E., Rosen, H. M., Ebeid, A. M., James, J. H., Keane, J. M., & Soeters, P. B. (1976) · PubMed · Cited by 580
S-adenosylmethionine in Liver Health, Injury, and Cancer
Lu, S. C., & Mato, J. M. (2012) · Physiological Reviews · doi:10.1152/physrev.00047.2011 · Cited by 554
Self-citationRegulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
Chiang, J. Y. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.006 · Cited by 546
Plasma Metabolomic Profile in Nonalcoholic Fatty Liver Disease
Kalhan, S. C., Guo, L., Edmison, J., Dasarathy, S., McCullough, A. J., Hanson, R. W., & Milburn, M. (2011) · Metabolism · doi:10.1016/j.metabol.2010.03.006 · Cited by 532
Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Uhlen, M., & Nielsen, J. (2014) · Nature Communications · doi:10.1038/ncomms4083 · Cited by 519
Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression
Corbin, K. D., & Zeisel, S. H. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834e7b4b · Cited by 502
Schwarz, J.-M., Linfoot, P., Dare, D., & Aghajanian, K. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.43 · Cited by 496
Pineda Torra, I., Claudel, T., Duval, C., Kosykh, V., Fruchart, J.-C., & Staels, B. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0120 · Cited by 487
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
Gaggini, M., Carli, F., Rosso, C., Buzzigoli, E., Marietti, M., Della Latta, V., Ciociaro, D., Abate, M. L., Gambino, R., Cassader, M., et al. (2018) · Hepatology · doi:10.1002/hep.29465 · Cited by 465
Self-citationLuukkonen, P. K., Zhou, Y., Sädevirta, S., Leivonen, M., Arola, J., Orešič, M., Hyötyläinen, T., & Yki-Järvinen, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.002 · Cited by 461
Self-citationLomonaco, R., Ortiz-Lopez, C., Orsak, B., Webb, A., Hardies, J., Darland, C., Finch, J., Gastaldelli, A., Harrison, S., Tio, F., et al. (2012) · Hepatology · doi:10.1002/hep.25539 · Cited by 459
Self-citationFrom NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Gastaldelli, A., & Cusi, K. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.07.002 · Cited by 455
Self-citationTargeting a ceramide double bond improves insulin resistance and hepatic steatosis
Chaurasia, B., Tippetts, T. S., Mayoral Monibas, R., Liu, J., Li, Y., Wang, L., Wilkerson, J. L., Sweeney, C. R., Pereira, R. F., Sumida, D. H., et al. (2019) · Science · doi:10.1126/science.aav3722 · Cited by 450
Human Insulin Resistance Is Associated With Increased Plasma Levels of 12α-Hydroxylated Bile Acids
Haeusler, R. A., Astiarraga, B., Camastra, S., Accili, D., & Ferrannini, E. (2013) · Diabetes · doi:10.2337/db13-0639 · Cited by 444
Puri, P., Daita, K., Joyce, A., Mirshahi, F., Santhekadur, P. K., Cazanave, S., Luketic, V. A., Siddiqui, M. S., Boyett, S., Min, H., et al. (2018) · Hepatology · doi:10.1002/hep.29359 · Cited by 426
Fiehn, O., Garvey, W. T., Newman, J. W., Lok, K. H., Hoppel, C. L., & Adams, S. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015234 · Cited by 421
Bowden, J. A., Heckert, A., Ulmer, C. Z., Jones, C. M., Koelmel, J. P., Abdullah, L., Ahonen, L., Alnouti, Y., Armando, A. M., Asara, J. M., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m079012 · Cited by 403
Self-citationMitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
Satapati, S., Kucejova, B., Duarte, J. A. G., Fletcher, J. A., Reynolds, L., Sunny, N. E., He, T., Nair, L. A., Livingston, K., Fu, X., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82204 · Cited by 399
The Role of the Gut Microbiota in Bile Acid Metabolism
Ramírez-Pérez, O., Cruz-Ramón, V., Chinchilla-López, P., & Méndez-Sánchez, N. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5672 · Cited by 391
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
Mouzaki, M., Wang, A. Y., Bandsma, R., Comelli, E. M., Arendt, B. M., Zhang, L., Fung, S., Fischer, S. E., McGilvray, I. G., & Allard, J. P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151829 · Cited by 385
Role of free radicals in liver diseases
Muriel, P. (2009) · Hepatology International · doi:10.1007/s12072-009-9158-6 · Cited by 374
Roles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., Min, J., Spann, N. J., McDonald, J. G., Kelly, S. L., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p056002 · Cited by 372
Chen, Y.-M., Liu, Y., Zhou, R.-F., Chen, X.-L., Wang, C., Tan, X.-Y., Wang, L.-J., Zheng, R.-D., Zhang, H.-W., Ling, W.-H., et al. (2016) · Scientific Reports · doi:10.1038/srep19076 · Cited by 358
Xia, J. Y., Holland, W. L., Kusminski, C. M., Sun, K., Sharma, A. X., Pearson, M. J., Sifuentes, A. J., McDonald, J. G., Gordillo, R., & Scherer, P. E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.007 · Cited by 348
Sookoian, S., & Pirola, C. J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i3.711 · Cited by 344
Lee, Y., Kim, S. U., Song, K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B., Kang, E. S., Cha, B., & Han, K. (2016) · Hepatology · doi:10.1002/hep.28376 · Cited by 340
Kast, H. R., Nguyen, C. M., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0712 · Cited by 336
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Ferslew, B. C., Xie, G., Johnston, C. K., Su, M., Stewart, P. W., Jia, W., Brouwer, K. L. R., & Sidney Barritt, A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3776-8 · Cited by 335
Rau, M., Rehman, A., Dittrich, M., Groen, A. K., Hermanns, H. M., Seyfried, F., Beyersdorf, N., Dandekar, T., Rosenstiel, P., & Geier, A. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640618804444 · Cited by 334
Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease
Scorletti, E., & Byrne, C. D. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161230 · Cited by 326
Sberna, A. L., Bouillet, B., Rouland, A., Brindisi, M. C., Nguyen, A., Mouillot, T., Duvillard, L., Denimal, D., Loffroy, R., Vergès, B., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13565 · Cited by 322
Burla, B., Arita, M., Arita, M., Bendt, A. K., Cazenave-Gassiot, A., Dennis, E. A., Ekroos, K., Han, X., Ikeda, K., Liebisch, G., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.s087163 · Cited by 312
Self-citationRole of ceramides in nonalcoholic fatty liver disease
Pagadala, M., Kasumov, T., McCullough, A. J., Zein, N. N., & Kirwan, J. P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.04.005 · Cited by 303
Zhang, L., Nichols, R. G., Correll, J., Murray, I. A., Tanaka, N., Smith, P. B., Hubbard, T. D., Sebastian, A., Albert, I., Hatzakis, E., et al. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1409055 · Cited by 302
Liver pathology in morbidly obese patients with and without diabetes.
Silverman, J. F., O’Brien, K. F., Long, S., Leggett-Frazier, N., Khazanie, P. G., Pories, W. J., Norris, H. T., & F., J. (1990) · PubMed · Cited by 301
Metabolic Messengers: ceramides
Summers, S. A., Chaurasia, B., & Holland, W. L. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0134-8 · Cited by 299
Feldstein, A. E., Lopez, R., Tamimi, T. A.-R., Yerian, L., Chung, Y.-M., Berk, M., Zhang, R., McIntyre, T. M., & Hazen, S. L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m007096 · Cited by 297
Gastaldelli, A., Harrison, S. A., Belfort-Aguilar, R., Hardies, L. J., Balas, B., Schenker, S., & Cusi, K. (2009) · Hepatology · doi:10.1002/hep.23116 · Cited by 285
Self-citationApostolopoulou, M., Gordillo, R., Koliaki, C., Gancheva, S., Jelenik, T., De Filippo, E., Herder, C., Markgraf, D., Jankowiak, F., Esposito, I., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1318 · Cited by 284
Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism
Lefere, S., & Tacke, F. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.02.004 · Cited by 278
Kantartzis, K., Thamer, C., Peter, A., Machann, J., Schick, F., Schraml, C., Konigsrainer, A., Konigsrainer, I., Krober, S., Niess, A., et al. (2009) · Gut · doi:10.1136/gut.2008.151977 · Cited by 273
Metabolomic identification of subtypes of nonalcoholic steatohepatitis
Alonso, C., Fernández-Ramos, D., Varela-Rey, M., Martínez-Arranz, I., Navasa, N., Van Liempd, S. M., Lavín Trueba, J. L., Mayo, R., Ilisso, C. P., de Juan, V. G., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.015 · Cited by 263
Self-citationMultiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes
Bjork, J. A., Butenhoff, J. L., & Wallace, K. B. (2011) · Toxicology · doi:10.1016/j.tox.2011.06.012 · Cited by 259
Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis
Tanaka, N., Matsubara, T., Krausz, K. W., Patterson, A. D., & Gonzalez, F. J. (2012) · Hepatology · doi:10.1002/hep.25630 · Cited by 249
The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes
Alberto González-Regueiro, J., Moreno-Castañeda, L., Uribe, M., & Carlos Chávez-Tapia, N. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5494 · Cited by 247 · cited 1×
“As discussed earlier, the gut microbiota modulates the bile acid pool, and the composition of the gut microbiome determines the deconjugation, dehydroxylation and oxidation of secondary bile acids 158 .”
Kotronen, A., Seppänen-Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepää, A.-L., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetes · doi:10.2337/db08-1074 · Cited by 245
Self-citationClinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver
Feldman, A., Eder, S. K., Felder, T. K., Kedenko, L., Paulweber, B., Stadlmayr, A., Huber-Schönauer, U., Niederseer, D., Stickel, F., Auer, S., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.318 · Cited by 239
Activation of Human Nuclear Receptors by Perfluoroalkylated Substances (PFAS)
Behr, A.-C., Plinsch, C., Braeuning, A., & Buhrke, T. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104700 · Cited by 235
Soga, T., Sugimoto, M., Honma, M., Mori, M., Igarashi, K., Kashikura, K., Ikeda, S., Hirayama, A., Yamamoto, T., Yoshida, H., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.031 · Cited by 234
Bechmann, L. P., Kocabayoglu, P., Sowa, J.-P., Sydor, S., Best, J., Schlattjan, M., Beilfuss, A., Schmitt, J., Hannivoort, R. A., Kilicarslan, A., et al. (2013) · Hepatology · doi:10.1002/hep.26225 · Cited by 233
Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease
Lake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D. G., Reily, M. D., Lehman-McKeeman, L. D., Vaillancourt, R. R., & Cherrington, N. J. (2015) · Amino Acids · doi:10.1007/s00726-014-1894-9 · Cited by 232
Ji, Y., Yin, Y., Li, Z., & Zhang, W. (2019) · Nutrients · doi:10.3390/nu11081712 · Cited by 230
Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression
Barr, J., Caballería, J., Martínez-Arranz, I., Domínguez-Díez, A., Alonso, C., Muntané, J., Pérez-Cormenzana, M., García-Monzón, C., Mayo, R., Martín-Duce, A., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr201223p · Cited by 226
Self-citationBile acids drive the newborn’s gut microbiota maturation
van Best, N., Rolle-Kampczyk, U., Schaap, F. G., Basic, M., Olde Damink, S. W. M., Bleich, A., Savelkoul, P. H. M., von Bergen, M., Penders, J., & Hornef, M. W. (2020) · Nature Communications · doi:10.1038/s41467-020-17183-8 · Cited by 226
Rosso, C., Kazankov, K., Younes, R., Esmaili, S., Marietti, M., Sacco, M., Carli, F., Gaggini, M., Salomone, F., Møller, H. J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.031 · Cited by 217
Self-citationThe FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology
Cagney, D. N., Sul, J., Huang, R. Y., Ligon, K. L., Wen, P. Y., & Alexander, B. M. (2018) · Neuro-Oncology · doi:10.1093/neuonc/nox242 · Cited by 214
Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition
Honda, A., Miyazaki, T., Iwamoto, J., Hirayama, T., Morishita, Y., Monma, T., Ueda, H., Mizuno, S., Sugiyama, F., Takahashi, S., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000395 · Cited by 213
Bile acid levels are increased in the liver of patients with steatohepatitis
Aranha, M. M., Cortez-Pinto, H., Costa, A., da Silva, I. B. M., Camilo, M. E., de Moura, M. C., & Rodrigues, C. M. P. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f4710a · Cited by 211
Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD
Rinella, M. E., Tacke, F., Sanyal, A. J., & Anstee, Q. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.019 · Cited by 209
Self-citationHoofnagle, J. H., Van Natta, M. L., Kleiner, D. E., Clark, J. M., Kowdley, K. V., Loomba, R., Neuschwander‐Tetri, B. A., Sanyal, A. J., Tonascia, J., & the Non‐alcoholic Steatohepatitis Clinical Research Network (NASH CRN) (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12352 · Cited by 201
Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease.
Morgan, M. Y., Milsom, J. P., & Sherlock, S. (1978) · Gut · doi:10.1136/gut.19.11.1068 · Cited by 200
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
Mato, J. M., Alonso, C., Noureddin, M., & Lu, S. C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i24.3009 · Cited by 199
Self-citationKotronen, A., Velagapudi, V. R., Yetukuri, L., Westerbacka, J., Bergholm, R., Ekroos, K., Makkonen, J., Taskinen, M.-R., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetologia · doi:10.1007/s00125-009-1282-2 · Cited by 198
Self-citationSystems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine
Nielsen, J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.002 · Cited by 197
Loomba, R., Quehenberger, O., Armando, A., & Dennis, E. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p055640 · Cited by 197
Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans
Ramsden, C. E., Ringel, A., Feldstein, A. E., Taha, A. Y., MacIntosh, B. A., Hibbeln, J. R., Majchrzak-Hong, S. F., Faurot, K. R., Rapoport, S. I., Cheon, Y., et al. (2012) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.08.004 · Cited by 192
Plasma amino-acid patterns in liver disease.
Morgan, M. Y., Marshall, A. W., Milsom, J. P., & Sherlock, S. (1982) · Gut · doi:10.1136/gut.23.5.362 · Cited by 191
Loguercio, C., De Girolamo, V., de Sio, I., Tuccillo, C., Ascione, A., Baldi, F., Budillon, G., Cimino, L., Di Carlo, A., Pia Di Marino, M., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00192-1 · Cited by 189
Lake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D., Reily, M. D., Lu, Z., Lehman-McKeeman, L. D., & Cherrington, N. J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.022 · Cited by 189
An Overview of Phenylalanine and Tyrosine Kinetics in Humans
Matthews, D. E. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1549s · Cited by 183
Recent advances in understanding bile acid homeostasis
Chiang, J. Y. (2017) · F1000Research · doi:10.12688/f1000research.12449.1 · Cited by 181
Gut-Liver Axis and Sensing Microbes
Szabo, G., Bala, S., Petrasek, J., & Gattu, A. (2010) · Digestive Diseases · doi:10.1159/000324281 · Cited by 179
Homocysteine and lipids: S‐Adenosyl methionine as a key intermediate
Obeid, R., & Herrmann, W. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.03.038 · Cited by 179
Mardinoglu, A., Bjornson, E., Zhang, C., Klevstig, M., Söderlund, S., Ståhlman, M., Adiels, M., Hakkarainen, A., Lundbom, N., Kilicarslan, M., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167422 · Cited by 176
Zhou, Y., Orešič, M., Leivonen, M., Gopalacharyulu, P. V., Hyysalo, J., Arola, J. T., Verrijken, A., Francque, S., Gaal, L. V., Hyötyläinen, T., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.046 · Cited by 168
Self-citationPrediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
Orešič, M., Hyötyläinen, T., Kotronen, A., Gopalacharyulu, P., Nygren, H., Arola, J., Castillo, S., Mattila, I., Hakkarainen, A., Borra, R. J. H., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2981-2 · Cited by 167
Self-citationMayo, R., Crespo, J., Martínez‐Arranz, I., Banales, J. M., Arias, M., Mincholé, I., Aller de la Fuente, R., Jimenez‐Agüero, R., Alonso, C., de Luis, D. A., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1188 · Cited by 164
Self-citationHuman PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids
Luukkonen, P. K., Nick, A., Hölttä-Vuori, M., Thiele, C., Isokuortti, E., Lallukka-Brück, S., Zhou, Y., Hakkarainen, A., Lundbom, N., Peltonen, M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.127902 · Cited by 161
Self-citationZein, C. O., Lopez, R., Fu, X., Kirwan, J. P., Yerian, L. M., McCullough, A. J., Hazen, S. L., & Feldstein, A. E. (2012) · Hepatology · doi:10.1002/hep.25778 · Cited by 160
Insulin resistance and the metabolism of branched-chain amino acids in humans
Adeva, M. M., Calviño, J., Souto, G., & Donapetry, C. (2012) · Amino Acids · doi:10.1007/s00726-011-1088-7 · Cited by 158
Luukkonen, P. K., Zhou, Y., Haridas, P. A. N., Dwivedi, O. P., Hyötyläinen, T., Ali, A., Juuti, A., Leivonen, M., Tukiainen, T., Ahonen, L. L., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.014 · Cited by 158
Self-citationKitajima, Y., Takahashi, H., Akiyama, T., Murayama, K., Iwane, S., Kuwashiro, T., Tanaka, K., Kawazoe, S., Ono, N., Eguchi, T., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1370-x · Cited by 157
Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men
Suvitaival, T., Bondia-Pons, I., Yetukuri, L., Pöhö, P., Nolan, J. J., Hyötyläinen, T., Kuusisto, J., & Orešič, M. (2018) · Metabolism · doi:10.1016/j.metabol.2017.08.014 · Cited by 146
Self-citationLee, H.-C., Inoue, T., Imae, R., Kono, N., Shirae, S., Matsuda, S., Gengyo-Ando, K., Mitani, S., & Arai, H. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0893 · Cited by 140
Pastore, A., Alisi, A., Giovamberardino, G. D., Crudele, A., Ceccarelli, S., Panera, N., Dionisi‐Vici, C., & Nobili, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151121202 · Cited by 134
Tanaka, Y., Shimanaka, Y., Caddeo, A., Kubo, T., Mao, Y., Kubota, T., Kubota, N., Yamauchi, T., Mancina, R. M., Baselli, G., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-320646 · Cited by 132
Bile acid receptors and gastrointestinal functions
Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K., & Alrefai, W. A. (2019) · Liver Research · doi:10.1016/j.livres.2019.01.001 · Cited by 130
Helsley, R. N., Varadharajan, V., Brown, A. L., Gromovsky, A. D., Schugar, R. C., Ramachandiran, I., Fung, K., Kabbany, M. N., Banerjee, R., Neumann, C. K., et al. (2019) · eLife · doi:10.7554/elife.49882 · Cited by 130
Dasarathy, S., Yang, Y., McCullough, A. J., Marczewski, S., Bennett, C., & Kalhan, S. C. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328345c8c7 · Cited by 124
Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD
Rinella, M. E., Tacke, F., Sanyal, A. J., Anstee, Q. M., & Workshop, O. B. O. T. P. O. T. A. (2019) · Hepatology · doi:10.1002/hep.30782 · Cited by 120
Self-citationHyötyläinen, T., Jerby, L., Petäjä, E. M., Mattila, I., Jäntti, S., Auvinen, P., Gastaldelli, A., Yki-Järvinen, H., Ruppin, E., & Orešič, M. (2016) · Nature Communications · doi:10.1038/ncomms9994 · Cited by 114
Self-citationMetabolism of dietary stearic acid relative to other fatty acids in human subjects
Emken, E. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.6.1023s · Cited by 114
Zhou, Y., Llauradó, G., Orešič, M., Hyötyläinen, T., Orho-Melander, M., & Yki-Järvinen, H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.010 · Cited by 112
Self-citationCirculating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver
Lehmann, R., Franken, H., Dammeier, S., Rosenbaum, L., Kantartzis, K., Peter, A., Zell, A., Adam, P., Li, J., Xu, G., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1760 · Cited by 109
Self-citationZhang, W., Wang, L.-W., Wang, L., Li, X., Zhang, H., Luo, L., Song, J.-C., & Gong, Z. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2775-x · Cited by 108
Valenzuela, R., Espinosa, A., González-Mañán, D., D'Espessailles, A., Fernández, V., Videla, L. A., & Tapia, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046400 · Cited by 106
Sunny, N. E., Kalavalapalli, S., Bril, F., Garrett, T. J., Nautiyal, M., Mathew, J. T., Williams, C. M., & Cusi, K. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00161.2015 · Cited by 106
The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
JASIRWAN, C. O. M., LESMANA, C. R. A., HASAN, I., SULAIMAN, A. S., & GANI, R. A. (2019) · Bioscience of Microbiota, Food and Health · doi:10.12938/bmfh.18-032 · Cited by 106
Cusi, K., Kashyap, S., Gastaldelli, A., Bajaj, M., & Cersosimo, E. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00624.2006 · Cited by 105
Self-citationBell, L. N., Wang, J., Muralidharan, S., Chalasani, S., Fullenkamp, A. M., Wilson, L. A., Sanyal, A. J., Kowdley, K. V., Neuschwander-Tetri, B. A., Brunt, E. M., et al. (2012) · Hepatology · doi:10.1002/hep.25805 · Cited by 104
Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression
Du, K., Chitneni, S. K., Suzuki, A., Wang, Y., Henao, R., Hyun, J., Premont, R. T., Naggie, S., Moylan, C. A., Bashir, M. R., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.12.006 · Cited by 103
Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects
Legry, V., Francque, S., Haas, J. T., Verrijken, A., Caron, S., Chávez-Talavera, O., Vallez, E., Vonghia, L., Dirinck, E., Verhaegen, A., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01397 · Cited by 101
Luukkonen, P. K., Tukiainen, T., Juuti, A., Sammalkorpi, H., Haridas, P. A. N., Niemelä, O., Arola, J., Orho-Melander, M., Hakkarainen, A., Kovanen, P. T., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.132158 · Cited by 99
Self-citationSchuster, S., Johnson, C. D., Hennebelle, M., Holtmann, T. M., Taha, A. Y., Kirpich, I., Eguchi, A., Ramsden, C. E., Papouchado, B. G., McClain, C. J., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m083741 · Cited by 95
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes
Meroni, M., Dongiovanni, P., Longo, M., Carli, F., Baselli, G., Rametta, R., Pelusi, S., Badiali, S., Maggioni, M., Gaggini, M., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102658 · Cited by 90
Self-citationSystems biology strategies to study lipidomes in health and disease
Hyötyläinen, T., & Orešič, M. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.06.001 · Cited by 89
Self-citationNeuschwander‐Tetri, B. A., & Bacon, B. R. (1996) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70483-1 · Cited by 88
Metabolic Modeling of Human Gut Microbiota on a Genome Scale: An Overview
Sen, P., & Orešič, M. (2019) · Metabolites · doi:10.3390/metabo9020022 · Cited by 86
Self-citationMultiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
Pirola, C. J., & Sookoian, S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i15.1601 · Cited by 85
Westerbacka, J., Kotronen, A., Fielding, B. A., Wahren, J., Hodson, L., Perttilä, J., Seppänen‐Laakso, T., Suortti, T., Arola, J. T., Hultcrantz, R. W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.064 · Cited by 84
Self-citationPan, X., Wen, S. W., Kaminga, A. C., & Liu, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-65051-8 · Cited by 79
Jeyapal, S., Kona, S. R., Mullapudi, S. V., Putcha, U. K., Gurumurthy, P., & Ibrahim, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29222-y · Cited by 78
Luzi, L., Castellino, P., & DeFronzo, R. A. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.2.e273 · Cited by 77
Kalhan, S. C., Edmison, J., Marczewski, S., Dasarathy, S., Gruca, L. L., Bennett, C., Duenas, C., & Lopez, R. (2011) · Clinical Science · doi:10.1042/cs20110060 · Cited by 75
Dong, S., Zhan, Z.-Y., Cao, H., Wu, C., Bian, Y., Li, J., Cheng, G., Liu, P., & Sun, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i15.2771 · Cited by 75
A critical review of endpoints for non-cirrhotic NASH therapeutic trials
Ratziu, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.001 · Cited by 74
The Yin and Yang of bile acid action on tight junctions in a model colonic epithelium
Sarathy, J., Detloff, S. J., Ao, M., Khan, N., French, S., Sirajuddin, H., Nair, T., & Rao, M. C. (2017) · Physiological Reports · doi:10.14814/phy2.13294 · Cited by 72
Luukkonen, P. K., Juuti, A., Sammalkorpi, H., Penttilä, A. K., Orešič, M., Hyötyläinen, T., Arola, J., Orho-Melander, M., & Yki-Järvinen, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.021 · Cited by 72
Self-citationProtein synthesis and breakdown in skin and muscle: a leg model of amino acid kinetics
Biolo, G., Gastaldelli, A., Zhang, X. J., & Wolfe, R. R. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.3.e467 · Cited by 71
Self-citationGut microbiome, microbial metabolites and the development of NAFLD
Caussy, C., & Loomba, R. S. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0058-x · Cited by 70
Circulating microbiota-derived metabolites: a “liquid biopsy?
Aragonès, G., Colom-Pellicer, M., Aguilar, C., Guiu-Jurado, E., Martínez, S., Sabench, F., Antonio Porras, J., Riesco, D., Del Castillo, D., Richart, C., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-019-0430-0 · Cited by 69
Kawanaka, M., Nishino, K., Oka, T., Urata, N., Nakamura, J., Suehiro, M., Kawamoto, H., Chiba, Y., & Yamada, G. (2015) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s79100 · Cited by 68
Nonalcoholic steatohepatitis is associated with a state of betaine‐insufficiency
Sookoian, S., Puri, P., Castaño, G. O., Scian, R., Mirshahi, F., Sanyal, A. J., & Pirola, C. J. (2017) · Liver International · doi:10.1111/liv.13249 · Cited by 68
Tremblay, S., Romain, G., Roux, M., Chen, X.-L., Brown, K., Gibson, D. L., Ramanathan, S., & Menendez, A. (2017) · Infection and Immunity · doi:10.1128/iai.00942-16 · Cited by 65
Qi, S., Xu, D., Li, Q., Xie, N., Xia, J., Huo, Q., Li, P., Chen, Q., & Huang, S. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.022 · Cited by 63
Hyysalo, J., Gopalacharyulu, P., Bian, H., Hyötyläinen, T., Leivonen, M., Jaser, N., Juuti, A., Honka, M.-J., Nuutila, P., Olkkonen, V. M., et al. (2014) · Diabetes · doi:10.2337/db13-0774 · Cited by 62
Self-citationFondevila, M. F., Fernandez, U., Gonzalez‐Rellan, M. J., Da Silva Lima, N., Buque, X., Gonzalez‐Rodriguez, A., Alonso, C., Iruarrizaga‐Lejarreta, M., Delgado, T. C., Varela‐Rey, M., et al. (2021) · Hepatology · doi:10.1002/hep.31290 · Cited by 62
Self-citationCaussy, C., Chuang, J.-C., Billin, A. N., Hu, T., Ya, W., Subramanian, G. M., Djedjos, C. S., Myers, R. P., Dennis, E. A., & Loomba, R. S. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820923904 · Cited by 60
Vilar‐Gomez, E., Yasells‐Garcia, A., Martinez‐Perez, Y., Calzadilla‐Bertot, L., Torres‐Gonzalez, A., Gra‐Oramas, B., Gonzalez‐Fabian, L., Villa‐Jimenez, O., Friedman, S. L., Diago, M., et al. (2016) · Hepatology · doi:10.1002/hep.28484 · Cited by 59
Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion
Dasarathy, S., Kasumov, T., Edmison, J. M., Gruca, L. L., Bennett, C., Duenas, C., Marczewski, S., McCullough, A. J., Hanson, R. W., & Kalhan, S. C. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00042.2009 · Cited by 55
Amino acid imbalance in patients with chronic liver diseases
Michitaka, K., Hiraoka, A., Kume, M., Uehara, T., Hidaka, S., Ninomiya, T., Hasebe, A., Miyamoto, Y., Ichiryu, M., Tanihira, T., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00614.x · Cited by 55
Cheng, J., Joyce, A., Yates, K. P., Aouizerat, B. E., & Sanyal, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044106 · Cited by 52
Santoro, N., Caprio, S., Giannini, C., Kim, G., Kursawe, R., Pierpont, B. M., Shaw, M. M., & Feldstein, A. E. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5466 · Cited by 51
Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)
Liu, Q., Liu, S., Chen, L., Zhao, Z., Du, S.-X., Dong, Q., Xin, Y., & Xuan, S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7781 · Cited by 51
Bril, F., Millán, L., Kalavalapalli, S., McPhaul, M. J., Caulfield, M. P., Martinez‐Arranz, I., Alonso, C., Ortiz Betes, P., Mato, J. M., & Cusi, K. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13285 · Cited by 50
Self-citationHaufe, S., Witt, H., Engeli, S., Kaminski, J., Utz, W., Fuhrmann, J. C., Rein, D., Schulz‐Menger, J., Luft, F. C., Boschmann, M., et al. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.03.013 · Cited by 48
Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution
Musso, G., Gambino, R., Cassader, M., Paschetta, E., & Sircana, A. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.01.003 · Cited by 47
Chen, J., Zheng, M., Liu, J., Luo, Y., Yang, W., Yang, J., Liu, J., Zhou, J., Xu, C., Zhao, F., et al. (2019) · Obesity · doi:10.1002/oby.22627 · Cited by 46
Valsesia, A., Saris, W. H. M., Astrup, A. V., Hager, J., & Masoodi, M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.137646 · Cited by 40
Self-citationEstimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans
Kalhan, S. C., Bugianesi, E., McCullough, A. J., Hanson, R. W., & Kelley, D. E. (2008) · Metabolism · doi:10.1016/j.metabol.2007.10.003 · Cited by 39
Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity
Lytle, K. A., Bush, N. C., Triay, J. M., Kellogg, T. A., Kendrick, M. L., Swain, J. M., Gathaiya, N. W., Hames, K. C., & Jensen, M. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00875 · Cited by 35
Jørgenrud, B., Jäntti, S. E., Mattila, I. M., Pöhö, P., Rnningen, K. S., Yki‐Järvinen, H., Orešič, M., & Hyötyläinen, T. (2015) · Bioanalysis · doi:10.4155/bio.15.16 · Cited by 35
Self-citationComprehensive Lipoprotein Characterization Using Lipidomics Analysis of Human Plasma
Christinat, N., & Masoodi, M. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00236 · Cited by 34
Self-citationFatty liver disrupts glycerol metabolism in gluconeogenic and lipogenic pathways in humans
Jin, E. S., Browning, J. D., Murphy, R. E., & Malloy, C. R. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m086405 · Cited by 31
Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics
Valsesia, A., Chakrabarti, A., Hager, J., Langin, D., Saris, W. H. M., Astrup, A. V., Blaak, E. E., Viguerie, N., & Masoodi, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-65936-8 · Cited by 31
Self-citationLeonetti, S., Herzog, R. I., Caprio, S., Santoro, N., & Tricò, D. (2020) · Children · doi:10.3390/children7120270 · Cited by 30
Kakazu, E., Sano, A., Morosawa, T., Inoue, J., Ninomiya, M., Iwata, T., Nakamura, T., Takai, S., Sawada, S., Katagiri, H., et al. (2019) · Hepatology Research · doi:10.1111/hepr.13346 · Cited by 27
Phosphatidylserine biosynthesis in mitochondria from ehrlich ascites tumor cells
Barańska, J. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90074-0 · Cited by 25
Wruck, W., & Adjaye, J. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i8.443 · Cited by 25
Dysregulation of Δ 4 -3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms
Valanejad, L., Ghareeb, M., Shiffka, S. J., Nadolny, C., Chen, Y., Guo, L., Verma, R., You, S., Akhlaghi, F., & Deng, R. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.10.005 · Cited by 25
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Brouwer, K. L. R., Barritt, A. S., Xie, G., Ferslew, B. C., Jia, W. P., Johnston, C., Stewart, P. W., & Su, M. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/v9a5-p335 · Cited by 24
Koch, M., Freitag‐Wolf, S., Schlesinger, S., Borggrefe, J., Hov, J. R., Jensen, M. K., Pick, J., Markus, M. R. P., Höpfner, T., Jacobs, G., et al. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.43 · Cited by 23
KEMETER, P., & Feichtinger, W. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47912-4 · Cited by 19
Stable isotope-based flux studies in nonalcoholic fatty liver disease
McCullough, A. J., Previs, S. F., & Kasumov, T. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.008 · Cited by 17
Zhu, L., Shahein, A., Choudhury, S., Liu, W., Bhatia, T., Baker, R. D., Lee, T., & Baker, S. S. (2018) · Trends in Cell & Molecular Biology · doi:10.31300/tcmb.13.2018.47-56 · Cited by 17
Christinat, N., Valsesia, A., & Masoodi, M. (2020) · Biomolecules · doi:10.3390/biom10071049 · Cited by 16
Self-citationIshikawa, T., Kubota, T., Horigome, R., Kimura, N., Honda, H., Iwanaga, A., Seki, K., Honma, T., & Yoshida, T. (2013) · PubMed · doi:10.5754/hge13488 · Cited by 11
Ramos‐Molina, B., Castellano‐Castillo, D., Pastor, Ó., Ocaña-Wilhelmi, L., Fernández‐García, D., Romero‐Gómez, M., Cardona, F., & Tinahones, F. J. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3612-2 · Cited by 11
Human gene therapy protocols: RAC review
Gj, M., & Anderson, W. (1995) · Science · doi:10.1126/science.7761842 · Cited by 9
KAHL, S., Nowotny, B., Straßburger, K., Bierwagen, A., Klüppelholz, B., Hoffmann, B. H., Giani, G., Nowotny, P., Wallscheid, F., Hatziagelaki, E. E., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01773 · Cited by 6
Motoric and attentional behavior in infants of methadone-maintained women.
Hans, S. L., & Marcus, J. H. (1982) · PsycEXTRA Dataset · doi:10.1037/e470032004-001 · Cited by 5
The use of bromocriptine for testing central dopaminergic reactivity
Allain, H., Reymann, J., Bentué‐Ferrer, D., Pape, D., van den Driessche, J., & Sabouraud, O. (1980) · Psychopharmacology · doi:10.1007/bf00427893 · Cited by 4
NAFLD and Insulin Resistance: A Multisystemic Disease
Gastaldelli, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_4 · Cited by 4
Self-citation
Research works printed but not linked: 1
- Wolfe, R. R. & Chinkes, D. L. Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis (Wiley, 2004).
Cited by
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Qiu, S., Cai, Y., Yao, H., Lin, C., Xie, Y., Tang, S., & Zhang, A. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01399-3 · Cited by 884
The multifaceted role of ferroptosis in liver disease
Chen, J., Li, X., Ge, C., Min, J., & Wang, F. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00941-0 · Cited by 665
Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463
“…phosphorylation, production of reactive oxygen species (ROS), formation of advanced glycated end-products, accumulation of toxic lipids such as diacylglycerols (DAG), ceramides and long-chain fatty acyl-CoA, which have been shown to promote inflammation and impair cellular metabolism 108 .”
Self-citationGut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway
Nie, Q., Luo, X., Wang, K., Ding, Y., Jia, S., Zhao, Q., Li, M., Zhang, J., Zhuo, Y., Lin, J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.034 · Cited by 326
Metadata
- Authors
- Masoodi, M., Gastaldelli, A., Hyötyläinen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., Mato, J. M., Dufour, J.-F., & Orešič, M.
- Affiliations
- University Hospital of Bern (CH)
- Istituto di Fisiologia Clinica (IT)
- Örebro University (SE)
- Euskadiko Parke Teknologikoa (ES)
- Pfizer (United States) (US)
- Newcastle University (GB)
- Åbo Akademi University (FI)
- Corresponding author
- Masoodi, Mojgan
- Orešič, Matej
- ORCID
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-09-10
- Volume
- 18
- Issue
- 12
- Pages
- 835-856
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3197814387
- Cited by
- 451
- References
- 195
- Citations by year
- 2026: 69 · 2025: 104 · 2024: 109 · 2023: 95 · 2022: 70 · 2021: 4
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, metabolomics, lipidomics, biomarkers, non-invasive diagnosis, amino acid metabolism, lipid metabolism, circulating fatty acids, triglycerides, phospholipids, bile acids, metabolic pathways, metabolic syndrome
- MeSH terms
- Lipidomics, Amino Acids, Bile Acids and Salts, Glutathione, Humans, Insulin Resistance, Prognosis, Biomarkers, Disease Progression, Glutamic Acid, Lipid Metabolism, Metabolomics, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.